Alembic Pharmaceuticals shareholding pattern

APLLTD

HealthcareLarge

1032.6

3.40 (-0.33%)
Last updated on 18 Jul, 2025 | 09:58 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Alembic Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

69.67%

Mutual Fund

9.05%

Insurance

7.01%

Foreign Institutional Investors

3.96%

Domestic Institutional Investors

0.4%

Retail

9.9%

Others

0.01%

Total Promoters
MAR '25
69.67%
JUN '25
69.67%

Alembic Pharmaceuticals FAQs

As of 07-2025, the promoter shareholding in Alembic Pharmaceuticals stands at 69.67% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Alembic Pharmaceuticals is 3.96% and 0.4% respectively.

The retail shareholding of the Alembic Pharmaceuticals is 9.9%.

Changes in shareholding patterns of Alembic Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Alembic Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.